UNVERIFIEDSingle Source
Neoadjuvant durvalumab plus chemotherapy in resectable or borderline resectable non-small-cell lung cancer: the phase 2 MDT-BRIDGE trial - Nature
Nature|10/26/2026
M
MDT
4 stories tracked
Executive summary being generated...
Lindy
0
Breaking
0
Unverified
1
Activity (Last 30 Days)
1
2026-10-262026-10-26
Top Publishers
Nature1 stories